Literature DB >> 21221822

CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea--therapeutic difficulties and dilemmas.

Charalampos Mermigkis, Demetrios Mermigkis, Georgios Varouchakis, Sophia Schiza.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21221822     DOI： 10.1007/s11325-010-0476-7

Source DB:  PubMed          Journal:  Sleep Breath        ISSN： 1520-9512            Impact factor:   2.816


× No keyword cloud information.
  18 in total

Review 1.  Pharmacological approaches to the treatment of obstructive sleep apnoea.

Authors:  Malcolm Kohler; Konrad E Bloch; John R Stradling
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206

2.  Adverse side effects associated with prednisone in the treatment of patients with oral inflammatory ulcerative diseases.

Authors:  F Lozada; S Silverman; C Migliorati
Journal:  J Am Dent Assoc       Date:  1984-08       Impact factor: 3.634

3.  How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?

Authors:  Charalampos Mermigkis; Eleni Stagaki; Stavros Tryfon; Sophia Schiza; Anastasia Amfilochiou; Vlassios Polychronopoulos; Panagiotis Panagou; Nikolaos Galanis; Anastasios Kallianos; Demetrios Mermigkis; Antony Kopanakis; Georgios Varouchakis; Fotis Kapsimalis; Demosthenis Bouros
Journal:  Sleep Breath       Date:  2010-03-16       Impact factor: 2.816

4.  The effect of 1 week of continuous positive airway pressure treatment in obstructive sleep apnea patients with concomitant gastroesophageal reflux.

Authors:  Maroun Tawk; Suanne Goodrich; Gary Kinasewitz; William Orr
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

5.  Efficacy of mirtazapine in obstructive sleep apnea syndrome.

Authors:  David W Carley; Christopher Olopade; Ge S Ruigt; Miodrag Radulovacki
Journal:  Sleep       Date:  2007-01       Impact factor: 5.849

Review 6.  Sleep and breathing in idiopathic pulmonary fibrosis.

Authors:  K Rasche; M Orth
Journal:  J Physiol Pharmacol       Date:  2009-11       Impact factor: 3.011

7.  Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study.

Authors:  Jana R Cooke; Liat Ayalon; Barton W Palmer; Jose S Loredo; Jody Corey-Bloom; Loki Natarajan; Lianqi Liu; Sonia Ancoli-Israel
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062

8.  Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis.

Authors:  Vidya Krishnan; Meredith C McCormack; Stephen C Mathai; Shikhar Agarwal; Brittany Richardson; Maureen R Horton; Albert J Polito; Nancy A Collop; Sonye K Danoff
Journal:  Chest       Date:  2008-07-14       Impact factor: 9.410

9.  Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome.

Authors:  Claudio L Bassetti; Milena Milanova; Matthias Gugger
Journal:  Stroke       Date:  2006-03-16       Impact factor: 7.914

10.  Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea.

Authors:  Liat Ayalon; Sonia Ancoli-Israel; Carl Stepnowsky; Matthew Marler; Barton W Palmer; Lianqi Liu; Jose S Loredo; Jody Corey-Bloom; Deborah Greenfield; Jana Cooke
Journal:  Am J Geriatr Psychiatry       Date:  2006-02       Impact factor: 4.105
View more
  10 in total

1.  Should we routinely screen patients with idiopathic pulmonary fibrosis for nocturnal hypoxemia?

Authors:  Georgia Pitsiou; Vasilis Bagalas; Afroditi Boutou; Ioannis Stanopoulos; Paraskevi Argyropoulou-Pataka
Journal:  Sleep Breath       Date:  2012-05-06       Impact factor: 2.816

2.  Can we predict the survival of idiopathic pulmonary fibrosis patients? Sleep must be re-appreciated.

Authors:  Paschalis Steiropoulos
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

3.  Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis.

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Katerina Antoniou; Georgios Papadogiannis; Ioannis Giannarakis; Georgios Varouchakis; Nikolaos Siafakas; Sophia E Schiza
Journal:  Sleep Breath       Date:  2014-07-16       Impact factor: 2.816

4.  Insomnia and excessive daytime sleepiness in obstructive sleep apnea: only different clinical phenotypes?

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Sophia E Schiza
Journal:  Sleep Breath       Date:  2015-04-09       Impact factor: 2.816

5.  Obstructive sleep apnea in patients with interstitial lung diseases: past and future.

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Sophia E Schiza
Journal:  Sleep Breath       Date:  2013-04-12       Impact factor: 2.816

6.  CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep?

Authors:  Charalampos Mermigkis; Izolde Bouloukaki; Katerina M Antoniou; Demetrios Mermigkis; Kostas Psathakis; Ioannis Giannarakis; Georgios Varouchakis; Nikolaos Siafakas; Sophia E Schiza
Journal:  Sleep Breath       Date:  2013-02-06       Impact factor: 2.816

7.  Pulmonary Overlap Syndromes, with a focus on COPD and ILD.

Authors:  Katherine A Dudley; Atul Malhotra; Robert L Owens
Journal:  Sleep Med Clin       Date:  2014-09

8.  Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease-characterization and treatment compliance assessment.

Authors:  Ana Verónica Cardoso; Nuno Pereira; Inês Neves; Vanessa Santos; José Miguel Jesus; Natália Melo; Patrícia Caetano Mota; António Morais; Marta Drummond
Journal:  Can J Respir Ther       Date:  2018-08-01

Review 9.  Cough in Idiopathic Pulmonary Fibrosis.

Authors:  Jennifer Mann; Nicole S L Goh; Anne E Holland; Yet Hong Khor
Journal:  Front Rehabil Sci       Date:  2021-10-18

Review 10.  The Association between Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.

Authors:  Filip Franciszek Karuga; Piotr Kaczmarski; Bartosz Szmyd; Piotr Białasiewicz; Marcin Sochal; Agata Gabryelska
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.